The antagonistic effect of antipsychotic drugs on a HEK293 cell line stably expressing human α1A1-adrenoceptors

European Journal of Pharmacology

Volumn 596, Issue 1-3, 2008, Pages 32-40

  Nourian, Zahra ^a   Mulvany, Michael J ^a   Nielsen, Karsten Bork ^a   Pickering, Darryl S ^b   Kristensen, Torsten ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

1A Adrenoceptor isoform; Antipsychotic drug; Human subcutaneous arteries; Transfected human cell

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1A1 ADRENERGIC RECEPTOR; CALCIUM ION; COMPLEMENTARY DNA; HALOPERIDOL; NEUROLEPTIC AGENT; PHENYLEPHRINE; PRAZOSIN; RECEPTOR SUBTYPE; RISPERIDONE; SERTINDOLE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL LINE; CONCENTRATION (PARAMETERS); DRUG EFFECT; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL;

ANTIPSYCHOTIC AGENTS; ARTERIES; BINDING, COMPETITIVE; CALCIUM; CELL LINE; HALOPERIDOL; HUMANS; IMIDAZOLES; INDOLES; PHENYLEPHRINE; PRAZOSIN; PROTEIN ISOFORMS; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-1; RECOMBINANT PROTEINS; RISPERIDONE; SKIN; TRITIUM; VASCULAR RESISTANCE;

EID: 53049096195     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.014     Document Type: Article

References (42)

1. Andros E., Detmar-Hanna D., Suteparuk S., Gal J., and Gerber J.G. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur. J. Clin. Pharmacol. 50 (1996) 41-46
2. Arunlakshano O., and Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14 (1959) 48-58
3. Barnes T.R., and McPhillips M.A. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. Br. J. Psychiatr., Suppl. (1999) 34-43
4. Buckley N.A., and Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Safety 23 (2000) 215-228
5. Cahir M., Mawhinney T., and King D.J. Differential region-specific regulation of central alpha 1-adrenoceptor binding following chronic haloperidol and clozapine administration in the rat. Psychopharmacology (Berl) 172 (2004) 196-201
6. Chang D.J., Chang T.K., Yamanishi S.S., Salazar F.H., Kosaka A.H., Khare R., Bhakta S., Jasper J.R., Shieh I.S., Lesnick J.D., Ford A.P., Daniels D.V., Eglen R.M., Clarke D.E., Bach C., and Chan H.W. Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms. FEBS Letters 422 (1998) 279-283
7. Chen Z., Hague C., Hall R.A., and Minneman K.P. Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction. J. Biol. Chem. 281 (2006) 12414-12420
8. Coge F., Guenin S.P., Renouard-Try A., Rique H., Ouvry C., Fabry N., Beauverger P., Nicolas J.P., Galizzi J.P., Boutin J.A., and Canet E. Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors. Biochem. J. 343 Pt 1 (1999) 231-239
9. Deng X.F., Sculptoreanu A., Mulay S., Peri K.G., Li J.F., Zheng W.H., Chemtob S., and Varma D.R. Crosstalk between alpha-1A and alpha-1B adrenoceptors in neonatal rat myocardium: implications in cardiac hypertrophy. J. Pharmacol. Exp. Ther. 286 (1998) 489-496
10. Goudie A.J., Smith J.A., and Millan M.J. Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine. Psychopharmacology (Berl) 171 (2004) 212-222
11. Graham R.M., Perez D.M., Hwa J., and Piascik M.T. Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ. Res. 78 (1996) 737-749
12. Hawrylyshyn K.A., Michelotti G.A., Coge F., Guenin S.P., and Schwinn D.A. Update on human alpha1-adrenoceptor subtype signaling and genomic organization. Trends Pharmacol. Sci. 25 (2004) 449-455
13. Hieble J.P., Bylund D.B., Clarke D.E., Eikenburg D.C., Langer S.Z., Lefkowitz R.J., Minneman K.P., and Ruffolo Jr. R.R. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol. Rev. 47 (1995) 267-270
14. Hirasawa A., Horie K., Tanaka T., Takagaki K., Murai M., Yano J., and Tsujimoto G. Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor. Biochem. Biophys. Res. Commun. 195 (1993) 902-909
15. Hirasawa A., Shibata K., Horie K., Takei Y., Obika K., Tanaka T., Muramoto N., Takagaki K., Yano J., and Tsujimoto G. Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants. FEBS Lett. 363 (1995) 256-260
16. Ipsen M., Zhang Y., Dragsted N., Han C., and Mulvany M.J. The antipsychotic drug sertindole is a specific inhibitor of alpha1A-adrenoceptors in rat mesenteric small arteries. Eur. J. Pharmacol. 336 (1997) 29-35
17. Jarajapu Y.P., Johnston F., Berry C., Renwick A., McGrath J.C., MacDonald A., and Hillier C. Functional characterization of alpha1-adrenoceptor subtypes in human subcutaneous resistance arteries. J. Pharmacol. Exp. Ther. 299 (2001) 729-734
18. Kilpatrick G.J., Dautzenberg F.M., Martin G.R., and Eglen R.M. 7TM receptors: the splicing on the cake. Trends Pharmacol. Sci. 20 (1999) 294-301
19. Lane R.F., Blaha C.D., and Rivet J.M. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry. Brain Res. 460 (1988) 398-401
20. Lattion A.L., Diviani D., and Cotecchia S. Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor. J. Biol. Chem. 269 (1994) 22887-22893
21. Lidow M.S., Williams G.V., and Goldman-Rakic P.S. The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol. Sci. 19 (1998) 136-140
22. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
23. Mathias C.J. Orthostatic hypotension: causes, mechanisms, and influencing factors. Neurology 45 (1995) S6-11
24. Michelotti G.A., Price D.T., and Schwinn D.A. Alpha 1-adrenergic receptor regulation: basic science and clinical implications. Pharmacol. Ther. 88 (2000) 281-309
25. Mueck-Weymann M., Acker J., and Agelink M.W. Autonomic responses of blood vessels and sweat glands in patients with schizophrenia treated with olanzapine or clozapine. Psychopharmacology (Berl) 157 (2001) 368-372
26. Nasif F.J., Cuadra G.R., and Ramirez O.A. Effects of chronic risperidone on central noradrenergic transmission. Eur. J. Pharmacol. 394 (2000) 67-73
27. Nielsen B.S., Banke T.G., Schousboe A., and Pickering D.S. Pharmacological properties of homomeric and heteromeric GluR1o and GluR3o receptors. Eur. J. Pharmacol. 360 (1998) 227-238
28. Nourian Z., Mow T., Muftic D., Burek S., Pedersen M.L., Matz J., and Mulvany M.J. Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha(1)-adrenoceptor function. Psychopharmacology (Berl) 199 (2008) 15-27
29. Poon I.O., and Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J. Clin. Pharm. Ther. 30 (2005) 173-178
30. Prinssen E.P., Ellenbroek B.A., and Cools A.R. Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine. Eur. J. Pharmacol. 262 (1994) 167-170
31. Richelson E., and Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 68 (2000) 29-39
32. Rudner X.L., Berkowitz D.E., Booth J.V., Funk B.L., Cozart K.L., D'Amico E.B., El-Moalem H., Page S.O., Richardson C.D., Winters B., Marucci L., and Schwinn D.A. Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation 100 (1999) 2336-2343
33. Schmidt A.W., Lebel L.A., Howard Jr. H.R., and Zorn S.H. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur. J. Pharmacol. 425 (2001) 197-201
34. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van G.P., Lesage A.S., De L.K., and Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124 (1996) 57-73
35. Schwinn D.A., Lomasney J.W., Lorenz W., Szklut P.J., Fremeau Jr. R.T., Yang-Feng T.L., Caron M.G., Lefkowitz R.J., and Cotecchia S. Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J. Biol. Chem. 265 (1990) 8183-8189
36. Schwinn D.A., Johnston G.I., Page S.O., Mosley M.J., Wilson K.H., Worman N.P., Campbell S., Fidock M.D., Furness L.M., and Parry-Smith D.J. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. Ther. 272 (1995) 134-142
37. Silver H., Kogan H., and Zlotogorski D. Postural hypotension in chronically medicated schizophrenics. J. Clin. Psychiatry 51 (1990) 459-462
38. Sramek J.J., Mack R.J., Awni W., Hourani J., Jhee S.S., Barto S., and Cutler N.R. Two rapid-dose titrations of sertindole in patients with schizophrenia. J. Clin. Psychopharmacol. 17 (1997) 419-422
39. Takata Y., Kurihara J., Suzuki S., Okubo Y., and Kato H. A rabbit model for evaluation of chlorpromazine-induced orthostatic hypotension. Biol. Pharm. Bull. 22 (1999) 457-462
40. Wadenberg M.L., Hertel P., Fernholm R., Hygge B.K., Ahlenius S., and Svensson T.H. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats. J. Neural Transm. 107 (2000) 1229-1238
41. Walden P.D., Gerardi C., and Lepor H. Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J. Urol. 161 (1999) 635-640
42. Weinberg D.H., Trivedi P., Tan C.P., Mitra S., Perkins-Barrow A., Borkowski D., Strader C.D., and Bayne M. Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c. Biochem. Biophys. Res. Commun. 201 (1994) 1296-1304